FDA approves Inlexzo for bladder cancer
The U.S. Food and Drug Administration has approved Inlexzo (gemcitabine intravesical system) for the treatment of patients with certain types of bladder cancer.
Sep 11, 2025
0
20
Pathological Conditions, Signs and Symptoms: News and Research on Disease Progression
MeSH tree: C23.550.291.656
FDA approves papzimeos for adults with recurrent respiratory papillomatosis
The U.S. Food and Drug Administration has approved Papzimeos (zopapogene imadenovec-drba) for the treatment of adults with recurrent respiratory papillomatosis (RRP).
Aug 21, 2025
0
10
Clinical trial shows newborns with spinal muscular atrophy can start treatment at birth
Spinal muscular atrophy (SMA) is a rare genetic condition that causes progressive muscle weakness, which, when untreated, prevents infants with the most severe form from gaining motor development—never gaining the ability ...
Aug 14, 2025
0
83
Immunotherapy drug improves high-risk blood cancer outcomes in clinical trial
A Peter Mac-initiated clinical trial suggests a way to dramatically improve outcomes in patients with high-risk forms of large B-cell lymphoma, who otherwise have a 50% chance of cure from conventional therapy.
Jun 19, 2025
0
27
Studies identify predictors and outcomes in systemic sclerosis
The Very Early Diagnosis of Systemic Sclerosis (VEDOSS) criteria identify red flags as puffy fingers, abnormal nailfold capillaroscopy, and specific autoantibodies in patients with Raynaud's phenomenon as a very early disease ...
Jun 12, 2025
0
14
Evidence of accelerated aging found in children with multiple sclerosis
Researchers from the University of California San Diego School of Medicine have discovered that children living with multiple sclerosis (MS) show signs of accelerated biological aging, even in their teenage years. The research, ...
Jun 9, 2025
0
19
Addition of regional nodal irradiation does not decrease rates of invasive breast cancer recurrence, study finds
Recent results from the NRG-NSABP B-51/RTOG 1304 clinical study showed that the addition of regional nodal irradiation (RNI) does not decrease the rates of invasive breast cancer recurrence in patients whose positive axillary ...
Jun 5, 2025
0
16
Study: Pre-operative THP leads to pCR in 64% of early-stage HER2+ ER- breast cancer patients
Patients with Stage II and III (early-stage) HER2+ breast cancer usually undergo preoperative therapy with multi-agent chemotherapy in combination with anti-HER2 antibodies, followed by surgery. A less intensive, reduced ...
Jun 2, 2025
0
21
New treatment combination for rectal cancer patients offers improved rates of complete remission
A new trial of patients with advanced rectal cancer has found that the addition of immunotherapy treatment alongside extended radiotherapy led to better rates of remission.
May 9, 2025
0
26
Uncovering inequalities in breast cancer immunotherapy access
Triple-negative breast cancer (TNBC) is an aggressive form of the disease that accounts for 15% of all breast cancer cases. Black women are twice as likely as white women to be diagnosed with TNBC and 28% more likely to die ...
Feb 18, 2025
0
15
